Telesis Bio Common Stock

As of the most recent data (September 2024), TBIO shows a common stock of $0. That compares with $5K in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TBIO's common stock is now $0 (was $5K) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Telesis Bio is outperforming or lagging.

Tracking TBIO's common stock over time shows whether Telesis Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $5K in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Telesis Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $0) with ownership activity and broader fundamentals.

Telesis Bio's common stock is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.